U.S. Markets close in 2 hrs 12 mins
  • S&P 500

    4,011.27
    +40.00 (+1.01%)
     
  • Dow 30

    32,597.27
    +203.02 (+0.63%)
     
  • Nasdaq

    11,871.11
    +155.03 (+1.32%)
     
  • Russell 2000

    1,764.32
    +11.68 (+0.67%)
     
  • Crude Oil

    73.16
    -0.04 (-0.05%)
     
  • Gold

    1,968.70
    -4.80 (-0.24%)
     
  • Silver

    23.53
    +0.11 (+0.47%)
     
  • EUR/USD

    1.0844
    -0.0004 (-0.0325%)
     
  • 10-Yr Bond

    3.5660
    +0.0020 (+0.06%)
     
  • Vix

    19.29
    -0.68 (-3.41%)
     
  • GBP/USD

    1.2315
    -0.0023 (-0.1872%)
     
  • USD/JPY

    132.6200
    +1.7450 (+1.3333%)
     
  • BTC-USD

    28,210.27
    +1,391.83 (+5.19%)
     
  • CMC Crypto 200

    615.50
    +14.53 (+2.42%)
     
  • FTSE 100

    7,564.27
    +80.02 (+1.07%)
     
  • Nikkei 225

    27,883.78
    +365.53 (+1.33%)
     

This Beaten-Down Growth Stock Has Significant Upside Potential. Time to Buy?

This Beaten-Down Growth Stock Has Significant Upside Potential. Time to Buy?

Shareholders of medical technology company InMode (NASDAQ: INMD) have not had a great 2022; the stock has fallen roughly 50% since the beginning of the year. Here are three reasons to consider InMode as a long-term growth stock for your portfolio. InMode designs and builds non-invasive medical equipment for cosmetic procedures like face and body contouring, hair removal, and women's wellness.